SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Earliest Event Reported: April 25, 2001
GreatBio Technologies, Inc.
--------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-26057 82-0507874
---------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification No.)
150 Lucius Gordon Drive,
West Henrietta, NY 14586
----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (716) 214-2441
ITEM 4. CHANGE IN REGISTRANT'S CERTIFIYING ACCOUNTANTS
(a) Previous independent accountants
On April 25, 2001, GreatBio Technologies, Inc. dismissed
Arthur Andersen LLP as its independent accountants. The
Registrant's Board of Directors approved the decision to
change independent accountants. Arthur Andersen LLP issued no
reports on the financial statements. Arthur Andersen LLP was
engaged from January 15, 2001 through April 24, 2001 and during
such period there have been no disagreements with Arthur
Andersen LLP on any matter of accounting principles or
practices, financial statement disclosure, auditing scope or
procedure, which disagreements if not resolved to the
satisfaction of Arthur Andersen LLP would have caused them to
make reference thereto in their report to be issued on the
financial statements. During the period in which Arthur
Andersen LLP was engaged there have been no reportable events
as defined in Regulation S-K Item 304(a)(1)(v). The
Registrant has requested that Arthur Andersen LLP furnish
it with a letter addressed to the SEC stating whether or not
it agrees with the above statements. A copy of such letter,
dated May 4, 2001, is filed as Exhibit 16 to this Form 8-K.
(b) New independent accountants
The Registrant engaged Goldstein Golub Kessler LLP as its new
independent accountants as of April 25, 2001. During the
two most recent fiscal years and through April 25, 2001,
the Registrant has not consulted with Goldstein Golub Kessler
LLP regarding either (i) the application of accounting
principles to a specified transaction, either completed or
proposed; or the type of audit opinion that might be rendered
on the Registrant's financial statements, and neither a
written report nor oral advice was provided to the Registrant
that was an important factor considered by the Registrant in
reaching a decision as to the accounting, auditing or
financial reporting issue; or (ii) any matter that was
either the subject of a disagreement, as that term is defined
in Item 304(a)(1)(iv) of Regulation S-K and the related
instructions to Item 304 of Regulation S-K, or a reportable
event, as that term is defined in Item 304(a)(1)(v) of
Regulation S-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
Page
(16) Letter regarding change in certifying accountant. 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: May 3, 2001
GreatBio Technologies, Inc.
By: /s/ Michael L. Weiner
----------------------------
Name: Michael L. Weiner
Title: President